TOP TIERMARKET NEWSWIRE
News & sentiment

PRELUDE THERAPEUTICS (PRLD) — News & AI sentiment

PRELUDE THERAPEUTICS (PRLD) news roundup. 1 story in the past week, 3 over 30 days. Average 30-day sentiment is 55.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
3
avg sentiment 55.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

PRLD news in the last 24 hours, 7 days, 30 days and 90 days

How much PRLD coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPRLD storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days163/100PRLD headlines →
Last 30 days355.7/100PRLD headlines →
Last 90 days2159.9/100PRLD headlines →

Latest stories on PRLD

1d ago
Oct 16
Oct 16
H.C. Wainwright reiterates Prelude Therapeutics stock rating at buy
Investing.com Analyst Ratings58 · neutralanalyst
Oct 14
Citizens reiterates Prelude Therapeutics stock rating on Lilly deal
Investing.com Analyst Ratings58 · neutralanalyst
Oct 14
Oct 13
Oct 13
Oct 13
Oct 13
Oct 13
Oct 6
Sep 17
Sep 17
Sep 11
Sep 11
Sep 10
Sep 10
Sep 10
Sep 10
Aug 23
Aug 20
Aug 11
Aug 11
Aug 11
Aug 11
Open PRLD in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →